Anson Funds Management LP Coll Plant Biotechnologies LTD Transaction History
Anson Funds Management LP
- $542 Million
- Q2 2025
A detailed history of Anson Funds Management LP transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Anson Funds Management LP holds 159,401 shares of CLGN stock, worth $502,113. This represents 0.04% of its overall portfolio holdings.
Number of Shares
159,401Holding current value
$502,113% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding CLGN
# of Institutions
20Shares Held
2.66MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC547KShares$1.72 Million0.08% of portfolio
-
Pinnacle Associates LTD507KShares$1.6 Million0.01% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.46 Million0.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$870,7542.69% of portfolio
-
Heights Capital Management, Inc San Francisco, CA275KShares$866,5080.1% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $34.9M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...